SIRT1 and metabolic dysfunction-associated steatotic liver disease: In NAFLD and NASH patients, miR-34a overexpression inhibits SIRT1 and dephosphorylates AMP kinase, thereby lowering the phosphorylation of HMG CoA reductase and altering liver cholesterol accumulation [40].